Terms: = Colorectal cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53
6841 results:
1. Apoptotic effect of 5-fluorouracil-doxorubicin combination on colorectal cancer cell monolayers and spheroids.
Bilgin S
Mol Biol Rep; 2024 May; 51(1):603. PubMed ID: 38698270
[TBL] [Abstract] [Full Text] [Related]
2. Identification and clinicopathological analysis of potential p73-regulated biomarkers in colorectal cancer via integrative bioinformatics.
Bareja C; Dwivedi K; Uboveja A; Mathur A; Kumar N; Saluja D
Sci Rep; 2024 Apr; 14(1):9894. PubMed ID: 38688978
[TBL] [Abstract] [Full Text] [Related]
3. [Detection and Significance of Molecular Markers in Immunotherapy and Targeted Therapy of colorectal cancer in Tibet].
Luo HH; Liu BY; Huo Z; BIANbazhaxi ; Wang Q; DUObula ; NImazhuoma ; DA Z; Wang H; Guo PP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Apr; 46(2):184-192. PubMed ID: 38686714
[TBL] [Abstract] [Full Text] [Related]
4. The Relationship of Microsatellite Instability with BRAF and p53 Mutations and Histopathological Parameters in colorectal Adenocarcinoma.
Gündoğar Ö; Bektaş S; Yıldırım E; Gönüllü D
Ann Ital Chir; 2024; 95(2):181-191. PubMed ID: 38684491
[TBL] [Abstract] [Full Text] [Related]
5. Exploring the Key Signaling Pathways and ncRNAs in colorectal cancer.
Lee YJ; Kim WR; Park EG; Lee DH; Kim JM; Shin HJ; Jeong HS; Roh HY; Kim HS
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674135
[TBL] [Abstract] [Full Text] [Related]
6. Somatic Mutations in Surgically Treated colorectal Liver Metastases: An Overview.
Wang J; Botvinov J; Bhatt AJ; Beyer K; Kreis ME; Adam M; Alseidi A; Margonis GA
Cells; 2024 Apr; 13(8):. PubMed ID: 38667294
[TBL] [Abstract] [Full Text] [Related]
7. Clinical impact of panel gene sequencing on therapy of advanced cancers of the digestive system: a retrospective, single center study.
Dreikhausen L; Klupsch A; Wiest I; Xiao Q; Schulte N; Betge J; Boch T; Brochhausen C; Gaiser T; Hofheinz RD; Ebert M; Zhan T
BMC Cancer; 2024 Apr; 24(1):526. PubMed ID: 38664720
[TBL] [Abstract] [Full Text] [Related]
8. Proteasome activation is critical for cell death induced by inhibitors of polo-like kinase 1 (PLK1) in multiple cancers.
Wang Y; Wang G; Xiang W; Liu X; Jiang M; Hu J
Eur J Pharmacol; 2024 Jun; 972():176558. PubMed ID: 38614382
[TBL] [Abstract] [Full Text] [Related]
9. Overcoming data scarcity in radiomics/radiogenomics using synthetic radiomic features.
Ahmadian M; Bodalal Z; van der Hulst HJ; Vens C; Karssemakers LHE; Bogveradze N; Castagnoli F; Landolfi F; Hong EK; Gennaro N; Pizzi AD; Beets-Tan RGH; van den Brekel MWM; Castelijns JA
Comput Biol Med; 2024 May; 174():108389. PubMed ID: 38593640
[TBL] [Abstract] [Full Text] [Related]
10. Promising Anticancer Prodrugs Based on Pt(IV) Complexes with Bis-organosilane Ligands in Axial Positions.
Navas F; Chocarro-Calvo A; Iglesias-Hernández P; Fernández-García P; Morales V; García-Martínez JM; Sanz R; De la Vieja A; García-Jiménez C; García-Muñoz RA
J Med Chem; 2024 Apr; 67(8):6410-6424. PubMed ID: 38592014
[TBL] [Abstract] [Full Text] [Related]
11. A narrative review on therapeutic potential of naringenin in colorectal cancer: Focusing on molecular and biochemical processes.
Zamanian MY; Golmohammadi M; Abdullaev B; García MO; Alazbjee AAA; Kumar A; Mohaamed SS; Hussien BM; Khalaj F; Hodaei SM; Shirsalimi N; Moriasi G
Cell Biochem Funct; 2024 Apr; 42(3):e4011. PubMed ID: 38583080
[TBL] [Abstract] [Full Text] [Related]
12. Characterization of cell cycle, inflammation, and oxidative stress signaling role in non-communicable diseases: Insights into genetic variants, microRNAs and pathways.
D'Antona S; Porro D; Gallivanone F; Bertoli G
Comput Biol Med; 2024 May; 174():108346. PubMed ID: 38581999
[TBL] [Abstract] [Full Text] [Related]
13. Biogenic Zinc Oxide Nanoparticles synthesized from
Berehu HM; Patnaik S
Nanotheranostics; 2024; 8(3):312-329. PubMed ID: 38577319
[TBL] [Abstract] [Full Text] [Related]
14. Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer.
D'Agostino E; Mastrodomenico L; Ponzoni O; Baldessari C; Piombino C; Pipitone S; Giuseppa Vitale M; Sabbatini R; Dominici M; Toss A
Cancer Treat Rev; 2024 May; 126():102723. PubMed ID: 38555857
[TBL] [Abstract] [Full Text] [Related]
15. Urocortin-1 promotes colorectal cancer cell migration and proliferation and inhibits apoptosis via inhibition of the p53 signaling pathway.
Guo X; Li Y; Chen X; Sun B; Guo X
J Cancer Res Clin Oncol; 2024 Mar; 150(3):163. PubMed ID: 38546882
[TBL] [Abstract] [Full Text] [Related]
16. Organosulfur Compounds in colorectal cancer Prevention and Progression.
McAlpine PL; Fernández J; Villar CJ; Lombó F
Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542713
[TBL] [Abstract] [Full Text] [Related]
17. Comparative analysis of single-cell transcriptome reveals heterogeneity and commonality in the immune microenvironment of colorectal cancer and inflammatory bowel disease.
Lv H; Mu Y; Zhang C; Zhao M; Jiang P; Xiao S; Sun H; Wu N; Sun D; Jin Y
Front Immunol; 2024; 15():1356075. PubMed ID: 38529274
[TBL] [Abstract] [Full Text] [Related]
18. Prediction of potential mechanisms of rhubarb therapy for colorectal cancer based on network pharmacological analysis and molecular docking.
Yang F; Li X; Zhang Y; Ren Y; Zhang J; Xiao K
Medicine (Baltimore); 2024 Mar; 103(12):e37477. PubMed ID: 38518016
[TBL] [Abstract] [Full Text] [Related]
19. CircHAS2 activates CCNE2 to promote cell proliferation and sensitizes the response of colorectal cancer to anlotinib.
Li H; Feng H; Zhang T; Wu J; Shen X; Xu S; Xu L; Wang S; Zhang Y; Jia W; Ji X; Cheng X; Zhao R
Mol Cancer; 2024 Mar; 23(1):59. PubMed ID: 38515149
[TBL] [Abstract] [Full Text] [Related]
20. Dual-specificity tyrosine-regulated kinase 2 exerts anti-tumor effects by induction of G1 arrest in lung adenocarcinoma.
Harada E; Yoshida S; Imaizumi Y; Kawamura A; Ohtsuka T; Yoshida K
Biochim Biophys Acta Gen Subj; 2024 Jun; 1868(6):130600. PubMed ID: 38508285
[TBL] [Abstract] [Full Text] [Related]
[Next]
